Yiyan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yiyan Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Lionel Sydney Zuckier
Division of Nuclear Medicine, Department of Radiology, Columbia University Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, United States
2 shared publications - Kim Bowers
Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry, Newark, New Jersey, USA
1 shared publication Nasrin Ghesani
1 shared publication- Nasrin Ghesani
Department of Radiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, UH H 141 Newark, NJ 07103, USA
1 shared publication Nasrin V. Ghesani
1 shared publicationNeena Mirani
1 shared publication
Latest Publications
- 1 May 2014
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 210 (5) , 486.e1-486.e2
Multiple distant adenomyosis mimicking carcinomatosis on FDG PET/CT
- 1 May 2014
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 210 (5) , 486.e1-486.e2
Multiple distant adenomyosis mimicking carcinomatosis on FDG PET/CT
- Open Access
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 5 (5) , 982-9
Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is not indicated or recommended in the initial staging of early breast cancer. Although it is valuable for detecting distant metastasis, providing prognostic information, identifying recurrence and evaluating response to chemotherapy, the role of FDG PET/CT in evaluating locoregional nodal status for initial staging of breast cancer has not yet been well-defined in clinical practice. FDG PET/CT has high specificity but compromised sensitivity for identifying axillary nodal disease in breast cancer. Positive axillary FDG PET/CT is a good predictor of axillary disease and correlates well with sentinel lymph node biopsy (SLNB). FDG PET/CT may help to identify patients with high axillary lymph node burden who could then move directly to axillary lymph node dissection (ALND) and would not require the additional step of SLNB. However, FDG PET/CT cannot replace SLNB or ALND due to unsatisfactory sensitivity. The spatial resolution of PET instruments precludes the detection of small nodal metastases. Although there is still disagreement regarding the management of internal mammary node (IMN) disease in breast cancer, it is known that IMN involvement is of prognostic significance, and IMN metastasis has been associated with higher rates of distant metastasis and lower overall survival rates. Limited clinical observations suggested that FDG PET/CT has advantages over conventional modalities in detecting and uncovering occult extra-axillary especially IMN lesions with upstaging the disease and an impact on the adjuvant management.
- 1 January 2014
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 5 (5) , 982-9
Open AccessRole of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is not indicated or recommended in the initial staging of early breast cancer. Although it is valuable for detecting distant metastasis, providing prognostic information, identifying recurrence and evaluating response to chemotherapy, the role of FDG PET/CT in evaluating locoregional nodal status for initial staging of breast cancer has not yet been well-defined in clinical practice. FDG PET/CT has high specificity but compromised sensitivity for identifying axillary nodal disease in breast cancer. Positive axillary FDG PET/CT is a good predictor of axillary disease and correlates well with sentinel lymph node biopsy (SLNB). FDG PET/CT may help to identify patients with high axillary lymph node burden who could then move directly to axillary lymph node dissection (ALND) and would not require the additional step of SLNB. However, FDG PET/CT cannot replace SLNB or ALND due to unsatisfactory sensitivity. The spatial resolution of PET instruments precludes the detection of small nodal metastases. Although there is still disagreement regarding the management of internal mammary node (IMN) disease in breast cancer, it is known that IMN involvement is of prognostic significance, and IMN metastasis has been associated with higher rates of distant metastasis and lower overall survival rates. Limited clinical observations suggested that FDG PET/CT has advantages over conventional modalities in detecting and uncovering occult extra-axillary especially IMN lesions with upstaging the disease and an impact on the adjuvant management.
- 1 July 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (7) , 580-581
FDG PET/CT and Renal Scan Demonstrations of Carcinoma in the Urinary Bladder and Bladder Diverticulum
Bladder tumors arising within or involving a bladder diverticulum are uncommon, and pose a unique diagnostic and therapeutic challenge. A 58-year-old man with bladder cancer diagnosed by cystoscopy had FDG PET/CT and 99mTc-MAG3 renal scan. The images demonstrated a large bladder diverticulum continuous from and within the tumor. Surgical pathology from transurethral partial resection of the bladder diverticulum showed high-grade carcinoma, mixed transitional with squamous cells invading into the muscularis propria.
- 1 July 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (7) , 580-581
FDG PET/CT and Renal Scan Demonstrations of Carcinoma in the Urinary Bladder and Bladder Diverticulum
Bladder tumors arising within or involving a bladder diverticulum are uncommon, and pose a unique diagnostic and therapeutic challenge. A 58-year-old man with bladder cancer diagnosed by cystoscopy had FDG PET/CT and 99mTc-MAG3 renal scan. The images demonstrated a large bladder diverticulum continuous from and within the tumor. Surgical pathology from transurethral partial resection of the bladder diverticulum showed high-grade carcinoma, mixed transitional with squamous cells invading into the muscularis propria.
- 1 June 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (6) , 469-470
FDG PET Differentiation of Tumor Recurrence From Post-Stereotactic Radiosurgical Scar in a Central Neurocytoma
Central neurocytoma is a rare benign tumor of neuronal origin. The tumor is often located in the ventricular system and can proliferate within the ventricle. Five months after stereotactic radiosurgery for recurrent neurocytoma, a 33-year-old woman had a 2.0-cm lesion in the right third ventricle on the MRI. FDG PET demonstrated intense uptake of the lesion. The subsequent MRI follow-up showed growth of the lesion and confirmed recurrence.
- 1 June 2013
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 38 (6) , 469-470
FDG PET Differentiation of Tumor Recurrence From Post-Stereotactic Radiosurgical Scar in a Central Neurocytoma
Central neurocytoma is a rare benign tumor of neuronal origin. The tumor is often located in the ventricular system and can proliferate within the ventricle. Five months after stereotactic radiosurgery for recurrent neurocytoma, a 33-year-old woman had a 2.0-cm lesion in the right third ventricle on the MRI. FDG PET demonstrated intense uptake of the lesion. The subsequent MRI follow-up showed growth of the lesion and confirmed recurrence.
- 1 July 2011
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 32 (7) , 554-562
Characterization of thymic lesions with F-18 FDG PET-CT
Thymic lesions may represent an unresolved diagnostic problem that often requires surgical procedure for an accurate diagnosis and staging. A noninvasive imaging study to determine the nature of thymic lesions would help to identify patients who are true candidates for surgery. Published preliminary clinical observations have suggested a role of fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography-computed tomography (PET-CT) in the characterization of thymic lesions. Benign uptake of the thymus on F-18 FDG PET-CT is seen in children and young adults, and may also indicate thymic hyperplasia in patients after chemotherapy or with Graves' disease. F-18 FDG PET-CT proves to be effective in differentiating thymic carcinoma from other entities within the thymus, and thymoma from thymic hyperplasia. The intensity of FDG uptake is useful for predicting the grade of malignancy in thymic epithelial tumors. However, the literature is equivocal with regard to the ability of F-18 FDG PET-CT to differentiate between invasive and noninvasive thymomas. Further larger studies are required to clarify the effectiveness and explore more clinical implications of F-18 FDG PET-CT on thymic lesions.
- 1 July 2011
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 32 (7) , 554-562
Characterization of thymic lesions with F-18 FDG PET-CT
Thymic lesions may represent an unresolved diagnostic problem that often requires surgical procedure for an accurate diagnosis and staging. A noninvasive imaging study to determine the nature of thymic lesions would help to identify patients who are true candidates for surgery. Published preliminary clinical observations have suggested a role of fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography-computed tomography (PET-CT) in the characterization of thymic lesions. Benign uptake of the thymus on F-18 FDG PET-CT is seen in children and young adults, and may also indicate thymic hyperplasia in patients after chemotherapy or with Graves' disease. F-18 FDG PET-CT proves to be effective in differentiating thymic carcinoma from other entities within the thymus, and thymoma from thymic hyperplasia. The intensity of FDG uptake is useful for predicting the grade of malignancy in thymic epithelial tumors. However, the literature is equivocal with regard to the ability of F-18 FDG PET-CT to differentiate between invasive and noninvasive thymomas. Further larger studies are required to clarify the effectiveness and explore more clinical implications of F-18 FDG PET-CT on thymic lesions.
- 1 July 2011
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (7) , e67-e68
Primary Umbilical Neoplasm Demonstrated on FDG PET/CT
Primary umbilical neoplasm is very rare, even though there are scattered case reports about the umbilical metastases known as Sister Mary Joseph's nodules. A 51-year-old man presented with an umbilical mass. Surgical biopsy showed infiltrating neoplasm with glandular and focal papillary architecture. FDG PET/CT demonstrated a focus of abnormal uptake located in the umbilicus, without evidence of a primary tumor elsewhere. Further investigations with EGD, colonoscopy, and cystoscopy were all negative for a neoplasm. The whole-body FDG PET/CT is an ideal imaging modality for evaluation of an umbilical lesion, especially identification or exclusion of a primary neoplasm elsewhere.
- 1 July 2011
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (7) , e67-e68
Primary Umbilical Neoplasm Demonstrated on FDG PET/CT
Primary umbilical neoplasm is very rare, even though there are scattered case reports about the umbilical metastases known as Sister Mary Joseph's nodules. A 51-year-old man presented with an umbilical mass. Surgical biopsy showed infiltrating neoplasm with glandular and focal papillary architecture. FDG PET/CT demonstrated a focus of abnormal uptake located in the umbilicus, without evidence of a primary tumor elsewhere. Further investigations with EGD, colonoscopy, and cystoscopy were all negative for a neoplasm. The whole-body FDG PET/CT is an ideal imaging modality for evaluation of an umbilical lesion, especially identification or exclusion of a primary neoplasm elsewhere.
- 15 June 2011
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 25 (8) , 536-546
Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT
HIV infection results in profound alterations of immunologic function that render the patient severely immunocompromised, and susceptible to malignancies and opportunistic infections. Three AIDS-defining malignancies include Kaposi’s sarcoma (KS), non-Hodgkin’s lymphoma (NHL) and invasive cervical cancer. In AIDS patients, KS is often aggressive and multifocal, with visceral involvement and widespread cutaneous and nodal spread; NHL is always high grade and often widely disseminated at the time of diagnosis with frequent involvement of extranodal sites; cervical cancer is invasive and has greater likelihood of progression and metastasis. Although there are very sparse systemic data available in the literature, limited studies has shown that FDG PET-CT is a valuable imaging technique in the diagnosis, staging, restaging and monitoring therapeutic response in these malignancies. In addition, a unique application of FDG PET/CT is the differentiation of cerebral lesions between lymphoma and toxoplasmosis in AIDS patients, which cannot be reliably achieved with either CT or MRI. HIV-associated opportunistic infections may involve different pathogens and multiple tissues, organs or systems. Some preliminary observations have revealed a promising role of FDG PET-CT in the diagnosis and identification of these infections such as tuberculosis, fever of unknown origin, pneumocystis pneumonia and candidiasis. However, it should be stressed that FDG PET-CT alone has no role in identifying the pathology of abnormalities. FDG PET-CT, at best, can localize the sites of abnormalities and impact on patient’s management in clinical decision making.
- 15 June 2011
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 25 (8) , 536-546
Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT
HIV infection results in profound alterations of immunologic function that render the patient severely immunocompromised, and susceptible to malignancies and opportunistic infections. Three AIDS-defining malignancies include Kaposi’s sarcoma (KS), non-Hodgkin’s lymphoma (NHL) and invasive cervical cancer. In AIDS patients, KS is often aggressive and multifocal, with visceral involvement and widespread cutaneous and nodal spread; NHL is always high grade and often widely disseminated at the time of diagnosis with frequent involvement of extranodal sites; cervical cancer is invasive and has greater likelihood of progression and metastasis. Although there are very sparse systemic data available in the literature, limited studies has shown that FDG PET-CT is a valuable imaging technique in the diagnosis, staging, restaging and monitoring therapeutic response in these malignancies. In addition, a unique application of FDG PET/CT is the differentiation of cerebral lesions between lymphoma and toxoplasmosis in AIDS patients, which cannot be reliably achieved with either CT or MRI. HIV-associated opportunistic infections may involve different pathogens and multiple tissues, organs or systems. Some preliminary observations have revealed a promising role of FDG PET-CT in the diagnosis and identification of these infections such as tuberculosis, fever of unknown origin, pneumocystis pneumonia and candidiasis. However, it should be stressed that FDG PET-CT alone has no role in identifying the pathology of abnormalities. FDG PET-CT, at best, can localize the sites of abnormalities and impact on patient’s management in clinical decision making.
- 1 March 2011
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (3) , 227-228
Super-Superscan on a Bone Scintigraphy
Superscans on bone scintigraphy have been described mostly in metastatic and metabolic bone diseases, with different patterns and appearances of radiotracer uptake. This is a report of bone scintigraphy demonstrating superimposed metastatic and metabolic superscan in a patient with prostate cancer, who subsequently developed renal osteodystrophy. Two years after the first bone scintigraphy showing multiple metastases, the patient developed renal insufficiency, hyperphosphoremia, and hypocalcemia. Repeat bone scintigraphy demonstrates significantly different appearance from that of the first study. Caution should be exercised when interpreting a bone scintigraphy in patients with known malignancy and coexisting renal failure or metabolic bone disease. Superimposed appearances of metastatic and metabolic superscan may obscure recognition of osseous metastases.
- 1 March 2011
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (3) , 227-228
Super-Superscan on a Bone Scintigraphy
Superscans on bone scintigraphy have been described mostly in metastatic and metabolic bone diseases, with different patterns and appearances of radiotracer uptake. This is a report of bone scintigraphy demonstrating superimposed metastatic and metabolic superscan in a patient with prostate cancer, who subsequently developed renal osteodystrophy. Two years after the first bone scintigraphy showing multiple metastases, the patient developed renal insufficiency, hyperphosphoremia, and hypocalcemia. Repeat bone scintigraphy demonstrates significantly different appearance from that of the first study. Caution should be exercised when interpreting a bone scintigraphy in patients with known malignancy and coexisting renal failure or metabolic bone disease. Superimposed appearances of metastatic and metabolic superscan may obscure recognition of osseous metastases.
- 1 February 2011
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (2) , 136-137
Metastatic Female Adnexal Tumor of Possible Wolffian Origin (FATWO) of the Appendix Demonstrated by FDG PET/CT
Both female adnexal tumor of possible wolffian origin (FATWO) and metastasis to the appendix from any primary tumor are extremely rare entities. The appendiceal metastasis from FATWO has not been reported, and there is a lack of the literature regarding FDG PET/CT study in both. We reported the case of an appendiceal metastasis from FATWO, demonstrated by F-18 FDG PET/CT. The case highlights the significance of FDG uptake in the appendix. When interpreting FDG PET/CT, caution should be exercised to identify uptake in the appendix, because it is easily misinterpreted as bowel activity.
- 1 February 2011
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (2) , 136-137
Metastatic Female Adnexal Tumor of Possible Wolffian Origin (FATWO) of the Appendix Demonstrated by FDG PET/CT
Both female adnexal tumor of possible wolffian origin (FATWO) and metastasis to the appendix from any primary tumor are extremely rare entities. The appendiceal metastasis from FATWO has not been reported, and there is a lack of the literature regarding FDG PET/CT study in both. We reported the case of an appendiceal metastasis from FATWO, demonstrated by F-18 FDG PET/CT. The case highlights the significance of FDG uptake in the appendix. When interpreting FDG PET/CT, caution should be exercised to identify uptake in the appendix, because it is easily misinterpreted as bowel activity.
- 1 July 2010
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 40 (4) , 294-315
Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy
- 1 July 2010
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 40 (4) , 294-315
Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy